BR0111819A - Isolated nucleic acid molecules, and isolated amino acid sequence - Google Patents

Isolated nucleic acid molecules, and isolated amino acid sequence

Info

Publication number
BR0111819A
BR0111819A BR0111819-6A BR0111819A BR0111819A BR 0111819 A BR0111819 A BR 0111819A BR 0111819 A BR0111819 A BR 0111819A BR 0111819 A BR0111819 A BR 0111819A
Authority
BR
Brazil
Prior art keywords
isolated
sequence
amino acid
nucleic acid
acid molecules
Prior art date
Application number
BR0111819-6A
Other languages
Portuguese (pt)
Inventor
Jose M Galarza
Theresa E Latham
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of BR0111819A publication Critical patent/BR0111819A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)

Abstract

"MOLéCULAS DE áCIDO NUCLéICO ISOLADAS, E, SEQ êNCIA DE AMINOáCIDO ISOLADA". A seq³ência de nucleotídeo completa de cada um dos oito segmentos da cepa do vírus da influenza A de filamento negativo A/Udorn/72 (H3N2) é divulgada, que fornece a seq³ência completa do genoma no sentido da mensagem antigenómica. A seq³ência é útil no diagnóstico e pode ser modificada pela mutação para gerar novas cepas variantes da influenza A."NUCLEIC ACID MOLECULES ISOLATED, AND SEQUENCE OF AMINO ACID ISOLATED". The complete nucleotide sequence of each of the eight segments of the A / Udorn / 72 (H3N2) negative strand influenza A virus strain is disclosed, which provides the complete genome sequence towards the antigenic message. The sequence is useful in diagnosis and can be modified by mutation to generate new variant influenza A strains.

BR0111819-6A 2000-06-23 2001-06-21 Isolated nucleic acid molecules, and isolated amino acid sequence BR0111819A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21365000P 2000-06-23 2000-06-23
PCT/US2001/019826 WO2002000884A2 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome

Publications (1)

Publication Number Publication Date
BR0111819A true BR0111819A (en) 2004-01-06

Family

ID=22795944

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111819-6A BR0111819A (en) 2000-06-23 2001-06-21 Isolated nucleic acid molecules, and isolated amino acid sequence

Country Status (10)

Country Link
EP (1) EP1292614A2 (en)
JP (1) JP2004514415A (en)
KR (1) KR20030013451A (en)
CN (1) CN1437612A (en)
AU (1) AU2001270033A1 (en)
BR (1) BR0111819A (en)
CA (1) CA2410284A1 (en)
IL (1) IL153005A0 (en)
MX (1) MXPA02012255A (en)
WO (1) WO2002000884A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160759A1 (en) * 2002-09-28 2006-07-20 Jianzhu Chen Influenza therapeutic
US8288523B2 (en) 2003-09-11 2012-10-16 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
RU2435855C2 (en) * 2004-12-24 2011-12-10 Солвей Байолоджикалз Б.В. Method for producing replicative influenza virus particles, cell composition (versions), cell culture composition and application thereof
MX339202B (en) * 2005-04-21 2016-05-13 Univ Florida Materials and methods for respiratory disease control in canines.
CA2605015C (en) 2005-05-06 2013-09-10 Gen-Probe Incorporated Compositions and assays to detect influenza virus a and b nucleic acids
EP2146575A4 (en) * 2007-04-12 2010-11-24 Alnylam Pharmaceuticals Inc Influenza polynucleotides, expression constructs, compositions, and methods of use
KR100913425B1 (en) 2007-05-14 2009-08-21 녹십자수의약품(주) Influenza virus and immunogenic composition comprising the same
KR20170061193A (en) * 2008-12-19 2017-06-02 유럽피안 몰레큘러 바이올로지 래보러토리 Polypeptide fragments comprising endonuclease activity and their use
EP2593569B1 (en) 2010-07-12 2018-01-03 Gen-Probe Incorporated Compositions and assays to detect seasonal h1 influenza a virus nucleic acids
CN107488743A (en) * 2017-08-30 2017-12-19 上海伯杰医疗科技有限公司 H3N2 subtype influenza virus genome sequencing methods

Also Published As

Publication number Publication date
IL153005A0 (en) 2003-06-24
JP2004514415A (en) 2004-05-20
EP1292614A2 (en) 2003-03-19
WO2002000884A2 (en) 2002-01-03
CN1437612A (en) 2003-08-20
MXPA02012255A (en) 2003-04-25
CA2410284A1 (en) 2002-01-03
AU2001270033A1 (en) 2002-01-08
WO2002000884A3 (en) 2002-08-15
KR20030013451A (en) 2003-02-14

Similar Documents

Publication Publication Date Title
BR0111819A (en) Isolated nucleic acid molecules, and isolated amino acid sequence
Amonsin et al. Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand
Schweiger et al. Antigenic drift and variability of influenza viruses
Bragstad et al. First introduction of highly pathogenic H5N1 avian influenza A viruses in wild and domestic birds in Denmark, Northern Europe
Zhang et al. Characterization of an H10N8 influenza virus isolated from Dongting lake wetland
Kaverin et al. Intergenic HA–NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes
ES2129386T1 (en) INFLUENZA VACCINE.
Takahashi et al. A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells
BR9813485A (en) Viruses of wasting syndrome or gradual multisystemic weakness after pig weaning.
Kilbourne et al. Influenza Virus Polypeptides and Antigens: Summary of Influeza Workshop I
HUP0303036A2 (en) Dna transfection system for the generation of infectious influenza virus
Colonno et al. Methylation of messenger RNA of Newcastle disease virus in vitro by a virion-associated enzyme.
BR0011159A (en) Method for producing attenuated negative strand virus RNA vaccines from cloned nucleotide sequences
US20070253978A1 (en) Copy choice recombination and uses thereof
Ellis et al. Molecular analysis of an outbreak of influenza in the United Kingdom
Horimoto et al. Biologic effects of introducing additional basic amino acid residues into the hemagglutinin cleavage site of a virulent avian influenza virus
Bressoud et al. Rapid detection of influenza virus H1 by the polymerase chain reaction
Lvov et al. Evolution of H4, H5 influenza A viruses in natural ecosystems in Northern Eurasia (2000–2002)
Zell et al. Ongoing evolution of swine influenza viruses: a novel reassortant
Smietanka et al. Full-length genome sequencing of the Polish HPAI H5N1 viruses suggests separate introductions in 2006 and 2007
BR9812778A (en) New proteins derived from reoviruses, nucleic acids encoding them, and applications of them
Wagner et al. Protease activation mutants elicit protective immunity against highly pathogenic avian influenza viruses of subtype H7 in chickens and mice
Jiang et al. Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses
Borger A SARS-like Coronavirus was expected but nothing was done to be prepared
BR0001906A (en) Process for the fermentative preparation of l-amino acids using corineform bacteria

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.